000 01075 a2200313 4500
005 20250513202944.0
264 0 _c20000310
008 200003s 0 0 eng d
022 _a0889-8588
024 7 _a10.1016/s0889-8588(05)70287-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLancet, J E
245 0 0 _aAcute myelogenous leukemia and aging. Clinical interactions.
_h[electronic resource]
260 _bHematology/oncology clinics of North America
_cFeb 2000
300 _a251-67 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAging
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aPrognosis
700 1 _aWillman, C L
700 1 _aBennett, J M
773 0 _tHematology/oncology clinics of North America
_gvol. 14
_gno. 1
_gp. 251-67
856 4 0 _uhttps://doi.org/10.1016/s0889-8588(05)70287-2
_zAvailable from publisher's website
999 _c10634371
_d10634371